Diagnosis and monitoring of virus-associated cancer using cell-free DNA
Document Type
Journal Article
Publication Date
5-13-2023
Journal
Current opinion in virology
Volume
60
DOI
10.1016/j.coviro.2023.101331
Abstract
Viral-associated cancers are a distinct group of malignancies with a unique pathogenesis and epidemiology. Liquid biopsy is a minimally invasive way to identify tumor-associated abnormalities in blood derivatives, such as plasma, to guide the diagnosis, prognosis, and treatment of patients with cancer. Liquid biopsy encompasses a multitude of circulating analytes with the most extensively studied being cell-free DNA (cfDNA). In recent decades, substantial advances have been made toward the study of circulating tumor DNA in nonviral-associated cancers. Many of these observations have been translated to the clinic to improve the outcomes of patients with cancer. The study of cfDNA in viral-associated cancers is rapidly evolving and reveals tremendous potential for clinical applications. This review provides an overview of the pathogenesis of viral-associated malignancies, the current state of cfDNA analysis in oncology, the current state of cfDNA analysis in viral-associated cancers, and perspectives for the future of liquid biopsies in viral-associated cancers.
APA Citation
Scholte, Larissa Ls; Bethony, Jeffrey M.; and Xian, Rena R., "Diagnosis and monitoring of virus-associated cancer using cell-free DNA" (2023). GW Authored Works. Paper 2910.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/2910
Department
Microbiology, Immunology, and Tropical Medicine